尽管收益较低，但 American Well 在关键财务指标上超过了 Decision Diagnostics。 American Well surpasses Decision Diagnostics in key financial metrics, despite lower earnings.

在美国,一个数字医疗的企业平台, 在包括机构所有权和收入在内的10种金融衡量标准中, 7种衡量标准中, 优于决策诊断。 American Well, an enterprise platform for digital healthcare, outperforms Decision Diagnostics in 7 out of 10 financial metrics including institutional ownership and revenue. American Well拥有更高的机构所有权(56.1%),收入较高,但收入较低,股票价格波动较大。 American Well has higher institutional ownership (56.1%) and revenue but lower earnings, with a more volatile stock price. 决定诊断侧重于基于智能手机的医疗记录技术和家用测试产品。 Decision Diagnostics focuses on smartphone-based medical record technologies and home testing products. 分析师看好 American Well，因为它的上行空间更高，以及净利润率和股本回报率等财务指标。 Analysts favor American Well for its higher probable upside and financial metrics like net margins and return on equity.